PHI with Adrenogenital syndrome without salt loss

How does this condition affect your private health insurance?

Adrenogenitales Syndrom ohne Salzverlust, a form of Congenital Adrenal Hyperplasia (CAH), results from a deficiency in the 21-hydroxylase enzyme. This leads to impaired cortisol production, causing the adrenal glands to overproduce androgens. Unlike the salt-wasting form, aldosterone levels are sufficient, preventing severe electrolyte imbalances. In affected females, signs of virilization, like ambiguous genitalia, are present at birth. Males may exhibit premature pubic hair and accelerated growth in early childhood. Without lifelong glucocorticoid replacement therapy to suppress androgen excess, individuals can develop short adult stature, infertility, and significant psychosocial challenges due to hormonal imbalances. Early diagnosis and consistent management are crucial.

PKV Risk Assessment

Very High Risk of Rejection

Individual, specialized PHI providers may still insure you, but with a significant surcharge.

Impact on Your Insurance Policy

Duration of Illness (Initial)

Initial diagnostic period ranging from days to several weeks, followed by lifelong management.

Duration of Illness (Lifetime)

Chronic, lifelong condition requiring continuous medical management.

Cost of Treatment (Initial)

Several thousands of dollars for diagnostic tests (hormone assays, genetic testing) and initial stabilization.

Cost of Treatment (Lifetime)

Tens of thousands to hundreds of thousands of dollars over a lifetime, including medication, regular monitoring, and specialist visits.

Mortality Rate

Very low with proper diagnosis and lifelong treatment; near negligible.

Risk of Secondary Damages

High if untreated, including short stature, infertility, psychological issues, and potential adrenal crises under stress. Low with consistent treatment.

Probability of Full Recovery

No complete recovery, as it is a genetic condition requiring lifelong hormone replacement therapy.

Underlying Disease Risk

Low, as CAH is the primary endocrine condition. Complications arise from the disease itself if not managed.

The information provided is for general informational purposes only and is not a substitute for professional medical or insurance advice. Always consult with a qualified professional for any health concerns or before making any insurance decisions.